Cbd Global Sciences Stock Profit Margin
| CBDNFDelisted Stock | USD 0.06 0.00 0.00% |
CBD Global Sciences fundamentals help investors to digest information that contributes to CBD Global's financial success or failures. It also enables traders to predict the movement of CBD Pink Sheet. The fundamental analysis module provides a way to measure CBD Global's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CBD Global pink sheet.
CBD |
CBD Global Sciences Company Profit Margin Analysis
CBD Global's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, CBD Global Sciences has a Profit Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
CBD Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CBD Global's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CBD Global could also be used in its relative valuation, which is a method of valuing CBD Global by comparing valuation metrics of similar companies.CBD Global is currently under evaluation in profit margin category among its peers.
CBD Fundamentals
| Return On Asset | -1.38 | |||
| Operating Margin | (2.71) % | |||
| Current Valuation | 14.44 M | |||
| Shares Outstanding | 49.46 M | |||
| Shares Owned By Insiders | 26.61 % | |||
| Price To Sales | 2.79 X | |||
| Revenue | 166.95 K | |||
| Gross Profit | 3.61 K | |||
| EBITDA | (4.6 M) | |||
| Net Income | (5.25 M) | |||
| Cash And Equivalents | 59.92 K | |||
| Total Debt | 1.34 M | |||
| Current Ratio | 0.09 X | |||
| Book Value Per Share | (0.26) X | |||
| Cash Flow From Operations | (1.14 M) | |||
| Earnings Per Share | (0.11) X | |||
| Beta | 0.49 | |||
| Market Capitalization | 5.93 M | |||
| Total Asset | 2.09 M | |||
| Z Score | -4.2 | |||
| Net Asset | 2.09 M |
About CBD Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CBD Global Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CBD Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CBD Global Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in CBD Pink Sheet
If you are still planning to invest in CBD Global Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CBD Global's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |